Valley Wealth Managers’s GSK GSK Stock Holding History

Valley Wealth Managers’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$83.2K	Hold	1,508	–	–	0.01%	193
2025 Q4	$74K	Hold	1,508	–	–	﹤0.01%	202
2025 Q3	$65.1K	Hold	1,508	–	–	﹤0.01%	197
2025 Q2	$57.9K	Hold	1,508	–	–	﹤0.01%	194
2025 Q1	$58.4K	Hold	1,508	–	–	﹤0.01%	200
2024 Q4	$51K	Hold	1,508	–	–	﹤0.01%	212
2024 Q3	$61.6K	Buy	+1,508	New	+$61.7K	﹤0.01%	206
2016 Q4	–	Sell	-1,714	Closed	-$92K	–	265
2016 Q3	$92K	Hold	1,714	–	–	0.01%	129
2016 Q2	$93K	Sell	1,714 -2,286	-57%	-$120K	0.01%	126
2016 Q1	$203K	Buy	+4,000	New	+$199K	0.03%	109

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Valley Wealth Managers's GSK Position: Q1 2026 in Review

Valley Wealth Managers held its GSK (GSK) position steady in Q1 2026 at 1,508 shares worth $83.2K. The position accounts for 0.01% of the portfolio, ranked #193.

Valley Wealth Managers first reported a position in GSK in Q1 2016 and has held it in 10 quarters since. The position peaked at $203K in Q1 2016. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Valley Wealth Managers held 1,508 shares of GSK worth $83.2K as of Q1 2026.
Valley Wealth Managers left its GSK share count unchanged in Q1 2026.
GSK made up 0.01% of Valley Wealth Managers's portfolio in Q1 2026, its #193 holding.
Valley Wealth Managers first reported a position in GSK in Q1 2016 and has held it in 10 quarters since.
Valley Wealth Managers's GSK position peaked at $203K in Q1 2016.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Valley Wealth Managers's 13F filing for Q1 2026, filed 6 May 2026.